NASDAQ: CNTXRUSSELL2000
Context Therapeutics Inc.
Healthcare · Biotechnology · Headquartered in Philadelphia, US
Price
Loading chart…
Overview
Context Therapeutics Inc., a biopharmaceutical company, develops products for the treatment of solid tumors. Its lead program candidate is CTIM-76, an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6. The company has a collaboration and licensing agreement with Integral Molecular, Inc. for the development of a CLDN6 bispecific monoclonal antibody for cancer therapy. The company was incorporated in 2015 and is headquartered in Philadelphia, Pennsylvania.
History & business model
This section is waiting to be written.
InvestWiki is community-edited. Contribute a plain-English history of Context Therapeutics Inc., its business model, key products, and controversies.